期刊文献+

氨氯地平联合厄贝沙坦治疗老年高血压的疗效观察

下载PDF
导出
摘要 目的:观察厄贝沙坦联合氨氯地平治疗老年高血压病的临床疗效。方法:将180例确诊为老年高血压病的患者,随机平均分为三组:氨氯地平组,每天口服氨氯地平5.0mg;厄贝沙坦组,每天口服厄贝沙坦150.0mg;联合用药组,采用厄贝沙坦联合氨氯地平治疗,用法用量同单独用药组。三组均治疗4周,观察治疗前后三组患者的临床疗效以及收缩压、舒张压降低的平均值。结果:三组患者治疗后,较治疗前收缩压、舒张压均降低,差异有统计学意义(P<0.05)。联合用药组总有效率显著高于两个单独用药组,联合用药组收缩压和舒张压的降低的平均值均高于单独用药组,差异有统计学意义(P<0.05)。三组不良反应的发生率比较差异无统计学意义(P>0.05)。结论:氨氯地平联合厄贝沙坦治疗老年高血压疗效显著,二者协同效果能够取得较好的控制血压效果。
作者 李华锋
出处 《中外医学研究》 2013年第9期34-35,共2页 CHINESE AND FOREIGN MEDICAL RESEARCH
  • 相关文献

参考文献4

二级参考文献31

  • 1王美丽,郑良荣.原发性高血压患者心率变异性分析[J].中国老年学杂志,2006,26(5):609-611. 被引量:22
  • 2李为民,刘巍.2005年中国高血压防治指南评介[J].中国实用内科杂志,2007,27(12):899-902. 被引量:73
  • 3Ruilope LM.Long-term protection in at-risk hypertensive patients:a role for nifedipine GITS? Blood Press 2002;11:106-9
  • 4The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group.Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic:the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).JAMA 2002;288:2981-97
  • 5Pitt B,Byington RP,Furberg CD,et al.for the PREVENT Investigators.Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events.Circulation 2000;102:1503-10
  • 6Jorgensen B,Simonsen S,Endresen K,et al.Restenosis and clinical outcome in patients treated with amlodipine after angioplasty:results from the coronary angioplasty amlodipine restenosis study (CAPARES).J Am Coll Cardiol 2000;35:592-9
  • 7Dahlof B,Sever PS,Poulter NR,et al.Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required,in the AngloScandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Ann (ASCOTBPLA):a multicentre randomised controlled trial.Lancet 2005;366(9489):895-906
  • 8Zanchetti A,Bond MG,Hennig M,et al.on behalf of the ELSA investigators.Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis:principal results of the European Lacidipine Study on Atherosclerosis (ELSA),a randomized,double-blind,long-term trial.Circulation 2002;106:2422-7
  • 9Phillips JE,Mason RP.Inhibition of oxidized LDL aggregation with a charged calcium antagonist amlodipine:role of electrostatic interactions.Atherosclerosis 2003;168:239-44
  • 10Tulenko TN,Chen M,Mason PE,et al.Physical effects of cholesterol on arterial smooth muscle membranes:evidence of immiscible cholesterol domains and alterations in bilayer width during atherogenesis.J Lipid Res 1998;39:947-56

共引文献255

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部